Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
France
10165256.8
Filed on 2010-06-08
10165256.8
Filed on 2010-06-08
Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
Finland
10165256.8
Filed on 2010-06-08
10165256.8
Filed on 2010-06-08
Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
Spain
10165256.8
Filed on 2010-06-08
10165256.8
Filed on 2010-06-08
Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
Estonia
10165256.8
Filed on 2010-06-08
10165256.8
Filed on 2010-06-08
Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
Denmark
10165256.8
Filed on 2010-06-08
10165256.8
Filed on 2010-06-08
Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
Germany
10165256.8
Filed on 2010-06-08
10165256.8
Filed on 2010-06-08
Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
Czech Republic
10165256.8
Filed on 2010-06-08
10165256.8
Filed on 2010-06-08
Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
Cyprus
10165256.8
Filed on 2010-06-08
10165256.8
Filed on 2010-06-08
Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
Switzerland
10165256.8
Filed on 2010-06-08
10165256.8
Filed on 2010-06-08